BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/04/2026

FDA Clears OZEMPIC (Semaglutide) Solution for Continued Sale

The FDA has determined that OZEMPIC solution, 2mg/1.5mL, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to continue being approved for use in ANDAs.

Source: Federal Register — Food and Drug AdministrationOpen original release →